We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$10.4B
AUM Growth
+$576M
Cap. Flow
+$80.3M
Cap. Flow %
0.78%
Top 10 Hldgs %
38.6%
Holding
1,407
New
91
Increased
858
Reduced
433
Closed
18

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$12.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
3
META icon
Meta Platforms (Facebook)
META
+$8.69M
4
V icon
Visa
V
+$8.21M
5
AMZN icon
Amazon
AMZN
+$6.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$7.31M
2
VRSK icon
Verisk Analytics
VRSK
+$5.19M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.16M
4
IT icon
Gartner
IT
+$4.49M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$3.73M

Sector Composition

Rank Sector Weight
1 Technology 35.83%
2 Consumer Discretionary 11.41%
3 Financials 11.04%
4 Healthcare 10.64%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CALM icon
1151
Cal-Maine
CALM
$3.72B
$252K ﹤0.01%
3,366
-701
-17% -$48.5K
IIPR icon
1152
Innovative Industrial Properties
IIPR
$1.56B
$249K ﹤0.01%
+1,847
New +$225K
RXO icon
1153
RXO
RXO
$3.68B
$249K ﹤0.01%
+8,877
New +$251K
FTDR icon
1154
Frontdoor
FTDR
$5.71B
$246K ﹤0.01%
+5,129
New +$222K
MDGL icon
1155
Madrigal Pharmaceuticals
MDGL
$12.6B
$245K ﹤0.01%
1,155
+38
+3% +$9.72K
BHVN icon
1156
Biohaven
BHVN
$2.43B
$244K ﹤0.01%
+4,885
New +$190K
PLXS icon
1157
Plexus
PLXS
$6.54B
$244K ﹤0.01%
+1,785
New +$217K
BROS icon
1158
Dutch Bros
BROS
$6.99B
$244K ﹤0.01%
7,604
+631
+9% +$22.2K
FUN icon
1159
Cedar Fair
FUN
$1.63B
$241K ﹤0.01%
+5,973
New +$273K
WD icon
1160
Walker & Dunlop
WD
$1.38B
$239K ﹤0.01%
+2,107
New +$221K
JWN
1161
DELISTED
Nordstrom
JWN
$238K ﹤0.01%
10,598
-112
-1% -$2.49K
ACLX
1162
DELISTED
Arcellx
ACLX
$238K ﹤0.01%
+2,844
New +$189K
DNLI icon
1163
Denali Therapeutics
DNLI
$3.94B
$237K ﹤0.01%
+8,135
New +$202K
LRN icon
1164
Stride
LRN
$3.55B
$237K ﹤0.01%
+2,775
New +$214K
NWL icon
1165
Newell Brands
NWL
$2.5B
$236K ﹤0.01%
30,789
+15,526
+102% +$111K
AXS icon
1166
AXIS Capital
AXS
$7.23B
$236K ﹤0.01%
+2,968
New +$222K
CRC icon
1167
California Resources
CRC
$4.7B
$236K ﹤0.01%
4,503
+77
+2% +$3.89K
AZN icon
1168
AstraZeneca
AZN
$255B
$236K ﹤0.01%
+1,516
New +$245K
RCM
1169
DELISTED
R1 RCM Inc. Common Stock
RCM
$236K ﹤0.01%
16,627
-2,950
-15% -$40.1K
BBIO icon
1170
BridgeBio Pharma
BBIO
$15.4B
$235K ﹤0.01%
9,245
+374
+4% +$9.82K
TXG icon
1171
10x Genomics
TXG
$8.45B
$235K ﹤0.01%
10,413
+200
+2% +$4.13K
PBH icon
1172
Prestige Consumer Healthcare
PBH
$2.43B
$234K ﹤0.01%
3,242
+100
+3% +$7.08K
CVCO icon
1173
Cavco Industries
CVCO
$4.39B
$233K ﹤0.01%
+545
New +$215K
FORM icon
1174
FormFactor
FORM
$8.61B
$233K ﹤0.01%
5,071
+146
+3% +$7.29K
IDCC icon
1175
InterDigital
IDCC
$8.64B
$233K ﹤0.01%
+1,645
New +$216K
45 46
47
48 49

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q3 2024 Portfolio in Review

As of Q3 2024, Xponance held 1,407 positions worth $10.4B, up 5.9% from $9.78B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance's Q3 2024 filing shows 91 new, 858 increased, 433 reduced and 18 closed positions. Its largest new stake was Smurfit Westrock: 106,066 shares worth $5.24M. The largest sale was Eli Lilly, an estimated $7.31M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Xponance's largest Q3 2024 buy was Smurfit Westrock: 106,066 shares worth $5.24M.
  • Xponance added most to Broadcom in Q3 2024, an estimated $12.5M increase.
  • Xponance's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $7.31M.
  • Xponance fully exited Invesco S&P 500 Concentrated QVM ETF in Q3 2024, selling an estimated $3.61M.
  • Xponance's ten largest holdings make up 39% of its $10.4B portfolio in Q3 2024.
  • Xponance opened 91 new positions and closed 18 in Q3 2024.
  • Xponance's portfolio value rose 5.9% quarter-over-quarter to $10.4B.

Based on Xponance's 13F filing for Q3 2024, filed 12 Nov 2024.